ARTV vs PDD · $37.3M cap vs P/E 8.4, rev $61.75B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
ARTV currently screens at market cap $37.3M. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the ARTV and PDD stock pages for the full models.
Not investment advice.